清肠温中方对缓解期溃疡性结肠炎的远期作用研究

孙中美; 陈晓伟; 胡立明; 王志斌; 史瑞; 姚玉璞; 毛堂友; 谭祥; 丁庞华; 李军祥

doi:10.3969/j.issn.1671-038X.2021.09.05

清肠温中方对缓解期溃疡性结肠炎的远期作用研究

- 1. 北京中医药大学(北京, 100029);
- 2. 北京中医药大学东方医院消化内科
基金项目:
国家中医药管理局中医药传承与创新"百千万"人才工程（歧黄工程）岐黄学者（李军祥）；北京中医药大学自主课题青年教师项目（No：2017-JYB-JS-089）；北京丰台区卫生计生系统科研项目（No：2016-45）

详细信息

通讯作者: 李军祥,E-mail:lijunxiang1226@163.com

中图分类号: R574.62

收稿日期: 2021-03-21

Study on Qingchang Wenzhong Decoction in the treatment of remission ulcerative colitis

- 1. Beijing University of Chinese Medicine, Beijing, 100029, China;
- 2. Department of Gastroenterology, Dongfang Hospital, Beijing University of Chinese Medicine

More Information

Corresponding author: LI Junxiang, E-mail: lijunxiang1226@163.com

Received Date: 21 March 2021

摘要

摘要: 目的：观察清肠温中方对缓解期溃疡性结肠炎患者维持缓解、预防复发的疗效以及用药安全性，为临床广泛应用提供科学依据。方法：采用前瞻性研究的方法，纳入缓解期溃疡性结肠炎患者50例，予清肠温中方治疗（1剂/d），治疗1年，患者每2个月接受随访，填写中医证候积分量表、生存质量积分表。治疗满1年时接受肠镜检查，患者纳入研究时及治疗满1年时均行安全性检查。结果：接受清肠温中方治疗1年后，患者维持缓解率为81.4%。治疗期间，患者便溏、腹痛、腹胀、食少、肢体倦怠、神疲懒言的症状较治疗前明显改善（P<0.05或P<0.01）；患者的生存质量包括肠道症状、社会能力、情感能力、全身症状较治疗前明显提高（P<0.05或P<0.01）。结论：清肠温中方能够有效维持缓解期溃疡性结肠炎的长期缓解，显著改善患者腹痛、便溏、腹胀、食少等临床症状，提高生存质量，且无明显不良反应。
- 溃疡性结肠炎 /
- 缓解期 /
- 清肠温中方 /
- 远期疗效
Abstract: Objective: To observe the safety of Qingchang Wenzhong Decoction and its effect on clinical symptoms, disease activity and quality of life of patients with remission ulcerative colitis, and to provide scientific basis for its wide application in clinic. Methods: A prospective study of 50 patients with remission ulcerative colitis were treated with Qingchang Wenzhong Decoction for 1 year. During the study, the patients were followed-up every 2 months, and the Traditional Chinese Medicine(TCM) syndrome scale and inflammatory bowel disease questionnaire scale were filled out. The patients were examined by enteroscopy at the end of the 12 months of treatment, and the safety tests were performed when the patients were included in the study and at the end of the 12 months of treatment. Results: After one year's treatment, 81.4% of patients remained in remission. The symptoms of loose stools, abdominal pain, abdominal distension, less food, body burnout and mental fatigue were significantly improved(P<0.05 or P<0.01), and the quality of life including intestinal symptoms, social ability, emotional ability, systemic symptoms(P<0.05 or P<0.01). Conclusion: Qingchang Wenzhong Decoction effectively prevent the relapse of ulcerative colitis patients in remission stage, relieving the clinical symptoms, such as abdominal pain, loose stool, abdominal distension, less food, and improving the quality of life without obvious adverse reactions.
- ulcerative colitis /
- remission period /
- Qingchang Wenzhong Decoction /
- long-term effect

HTML全文

参考文献(25)

[1]	Feuerstein JD, Moss AC, Farraye FA.Ulcerative Colitis[J].Mayo Clin Proc, 2019, 94(7):1357-1373.
[2]	俞媛, 王卿华, 陈媛洁, 等.痛泻要方对溃疡性结肠炎患者免疫功能及肠道黏膜屏障的调节作用[J].中国中西医结合消化杂志, 2020, 28(11):858-862.
[3]	Cui G, Yuan A.A Systematic Review of Epidemiology and Risk Factors Associated With Chinese Inflammatory Bowel Disease[J].Front Med, 2018, 5:183.
[4]	张歆, 施家芳, 赵培琳, 等.溃疡性结肠炎患者生活质量影响因素分析[J].成都中医药大学学报, 2018, 41(4):96-100.
[5]	Lichtenstein GR, Shahabi A, Seabury SA, et al.Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis[J].Clin Gastroenterol Hepatol, 2020, 18(4):889-897.
[6]	Eisenstein M.Ulcerative colitis:towards remission[J].Nature, 2018, 563(7730):S33.
[7]	刘润利, 刘力, 周铖, 等.溃疡性结肠炎的分期治疗[J].中国中西医结合消化杂志, 2021, 29(1):67-71.
[8]	Vermeire S, Chiorean M, Panés J, et al.Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis:Results from the Open-label Extension of the OASIS Study[J].J Crohns Colitis, 2021, 15(6):950-959.
[9]	汪青楠, 李娟梅, 倪瑶, 等.中医治疗溃疡性结肠炎的研究进展[J].吉林中医药, 2019, 39(9):1251-1255.
[10]	王志斌, 陈晨, 郭一, 等.清肠温中方治疗轻中度溃疡性结肠炎的临床研究[J].中国中西医结合杂志, 2018, 38(1):15-19.
[11]	中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2012年·广州)[J].胃肠病学, 2012, 17(12):763-781.
[12]	中国中西医结合学会消化系统疾病专业委员会.溃疡性结肠炎中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志, 2018, 26(2):105-111, 120-120.
[13]	郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社, 2002.
[14]	Guyatt G, Mitchell A, Irvine EJ, et al.A new measure of health status for clinical trials in inflammatory bowel disease[J].Gastroenterology, 1989, 96(3):804.
[15]	吴开春, 梁洁, 冉志华, 等.炎症性肠病诊断与治疗的共识意见(2018年·北京)[J].中国实用内科杂志, 2018, 38(9):796-813.
[16]	丛龙玲, 姚嘉茵, 吴宇金, 等.肠炎清合剂联合美沙拉嗪肠溶片维持治疗缓解期溃疡性结肠炎的临床疗效[J].中国实验方剂学杂志, 2021, 27(3):99-104.
[17]	齐相芬, 张仁诚, 胡文平, 等.自拟愈溃方维持缓解脾肾阳虚型溃疡性结肠炎的临床疗效观察[J].中国中西医结合消化杂志, 2015, 23(12):885-887.
[18]	陈开平, 马丽.中药汤剂内服及外用灌肠联合治疗溃疡性结肠炎的临床研究[J].四川中医, 2017, 35(3):74-76.
[19]	张厚, 刘耀武.针刺鬼眼穴联合膈下逐瘀汤治疗活动期湿热型溃疡性结肠炎临床观察[J].亚太传统医药, 2021, 17(5):75-79.
[20]	Mao TY, Shi R, Zhao WH, et al.Qingchang Wenzhong Decoction Ameliorates Dextran Sulphate Sodium-Induced Ulcerative Colitis in Rats by Downregulating the IP10/CXCR3 Axis-Mediated Inflammatory Response[J].Evid Based Complement Alternat Med, 2016, 2016:4312538.
[21]	Mao T, Li J, Liu L, et al.Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway[J].Evid Based Complement Alternat Med, 2017, 2017:4846876.
[22]	Sun Z, Pei W, Guo Y, et al.Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction[J].Evid Based Complement Alternat Med, 2019, 2019:9839474.
[23]	毛堂友, 程佳伟, 魏仕兵, 等.清肠温中方治疗溃疡性结肠炎84例[J].环球中医药, 2016, 9(4):479-481.
[24]	韩红坡.溃疡性结肠炎相关性结直肠癌危险因素分析及延续性护理效果评价[J].中国肛肠病杂志, 2021, 41(2):69-71.
[25]	Bopanna S, Ananthakrishnan AN, Kedia S, et al.Risk of Colorectal Cancer in Asian Patients With Ulcerative Colitis:A Systematic Review and Meta-Analysis[J].Lancet Gastroenterol Hepatol, 2017, 2(4):269-276.